9 3 7159 (Pergolide 0.25 mg)
This pill with imprint "9 3 7159" is Yellow, Elliptical / Oval and has been identified as Pergolide mesylate 0.25 mg. It is supplied by Teva Pharmaceuticals USA.
Pergolide is used in the treatment of tourette's syndrome; parkinson's disease; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Pergolide mesylate
- Imprint:
- 9 3 7159
- Strength:
- 0.25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7159
More about pergolide
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Permax
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
